Abzena, an integrated contract development and manufacturing organization (CDMO) for biologics, has announced an expansion of its analytical capabilities. The company will now offer GMP cell-based potency assays at its development and manufacturing sites in Cambridge, UK, and San Diego,
Abzena, a contract development and manufacturing organisation (CDMO) specialising in complex biologics and bioconjugates, has announced an expansion of its quality control (QC) testing capacity at its San Diego, California manufacturing site. This new laboratory aims to enhance testing services,
Abzena, a global CDMO specialising in complex biologics and bioconjugates, has introduced its enhanced mammalian cell line development platform, AbZelectPRO, as a standard offering for all customers. The platform now significantly reduces development timelines by more than 30%, enabling biopharma
Angiex, a biopharmaceutical company focused on developing innovative therapies for solid cancers, has begun patient dosing for its Phase 1 clinical trial of AGX101, a TM4SF1-directed Antibody-Drug Conjugate (ADC). The trial, which marks the first-in-human study for AGX101, is supported
Abzena, an end-to-end integrated contract development and manufacturing organization (CDMO) for complex biologics and bioconjugates, has teamed up with Argonaut Manufacturing Services, Inc., a cGMP CDMO serving the biopharmaceutical and diagnostics industries. The strategic partnership aims to provide a fully
Abzena an end-to-end integrated CDMO for complex biologics and bioconjugates has launched EpiScreen 2.0, an enhanced bioassay platform for predicting and evaluating immunogenicity risks in preclinical protein, antibody, and gene therapy therapeutics. The platform offers sensitive, multi-parametric, and data-rich assessments,
Abzena, a CDMO specialising in complex biologics and bioconjugates, has unveiled a significant expansion at its Bristol, PA bioconjugate development and cGMP manufacturing site. The expansion includes increased laboratory space, new equipment acquisitions, and upgrades to the existing facility. As
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
